Yuhan Corporation (000105.KS)
KSE · KRW · Healthcare · Drug Manufacturers - Specialty & Generic
₩65,200 (-4.26%) as of
Key statistics
- Market cap
- 4.80T
- Dividend yield
- 0.90%
- 52-week range
- 55,100.00 – 115,300.00
- Beta
- 0.43
- Revenue (TTM)
- 2.28T
- Profit margin
- 10.39%
- Volume
- 1.63k
About Yuhan Corporation
Yuhan Corporation operates as a pharmaceutical company in South Korea and internationally. It offers manufacturing services, such as custom manufacturing; process research and development of active pharmaceutical products (APIs) and intermediates; kilo and pilot-scale production of APIs and intermediates; commercial production of APIs and intermediates; production of chemical specialties; and analytical method development and regulatory support. The company also provides APIs and intermediates, including antibiotic, anti-thrombotic, anti-hyperlipidemics, and anti-hypertensive; and custom synthesis services through commercial supply in areas of anti-viral, anti-HIV, anti-HCV, anti-biotic, antihistamine, anti-diabetic, ß-lactamase inhibitor, CNS intermediate, PEG-compounds, and others. Yuhan Corporation was founded in 1926 and is headquartered in Seoul, South Korea.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Headquarters
- Seoul, South Korea
- Employees
- 2,082
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.